Article
Operational excellence benchmarking: Shaping the future of MedTech

Operational excellence benchmarking: Shaping the future of MedTech

November 13, 2024

Our first-in-industry tool enables MedTech firms to create data-driven operational strategies

The MedTech sector is facing growing cost pressure, making operational excellence (OPEX) more important than ever. Benchmarking is a vital part of this: Do you know how your company compares against competitors? What are the gaps between your firm’s performance and that of industry leaders, and what levers can you pull to improve results?

How does your company compare against peers? OPEX benchmarking is a vital part of gaining a competitive edge.
How does your company compare against peers? OPEX benchmarking is a vital part of gaining a competitive edge.
"Roland Berger and the University of St.Gallen have developed the world’s first dedicated MedTech OPEX benchmarking tool."
Portrait of Thilo Kaltenbach
Senior Partner
Munich Office, Central Europe

These can be difficult questions to answer. But now, Roland Berger and the University of St.Gallen have developed the world’s first dedicated MedTech OPEX benchmarking tool to help boost your company’s competitive edge and achieve lasting improvements.

Fully assess OPEX across an organization

Our MedTech OPEX benchmarking tool combines industrial data with science-based practices, principles, and philosophies to fully assess OPEX across an entire organization (see infographic). It has an end-to-end focus across each manufacturing site, while also covering network and corporate aspects. There are three main levels of information:

  1. Key performance indicators: Hard facts and outcome metrics to determine the performance of your organization.
  2. Implementation of leading tools and approaches: Assess the maturity of your organization to see if performance is built on solid foundations; discover which levers to pull to improve performance.
  3. Structural factors: A variety of contextual factors provide greater detail and enable more meaningful comparisons.

The benefits of MedTech OPEX benchmarking

Our MedTech OPEX benchmarking tool offers numerous benefits:

  • Obtain a data-driven, scientifically proven external perspective
  • Receive a holistic overview of your company’s strengths and weaknesses
  • Make meaningful comparisons to real high performers
  • Derive the right implications to make improvements with measurable and sustainable impact

"MedTech OPEX benchmarking enables meaningful comparisons to real high performers."
Portrait of Stephan Fath
Principal
Dusseldorf Office, Central Europe

Once you have completed the MedTech OPEX benchmarking, your business will receive an individual report per participating site. Each report comprises an extensive performance review, in-depth maturity assessment, and many more structural factors to clearly show the full picture. High performers and peer-group median benchmarking values show where your organization stands within the industry and your closest peers.

Additional activities, such as an implications and measure workshop, can be arranged upon agreement.

You can start benchmarking at any time, across as many sites as required. The initial questionnaire is Excel-based, ensuring easy management across your organization. While you and your on-site staff gather the data, Roland Berger and the University of St.Gallen team provide remote support. An outline of the process is shown below.

"This unique benchmarking tool allows to benchmark performance in a contextual environment, making sure to compare apples with apples."
Portrait of Marco Bühren
Principal
Munich Office, Central Europe

How we honed a precise benchmarking tool

It took a year for Roland Berger, the University of St.Gallen and a selected group of industry peers to develop the benchmark. Building on the foundation of St.Gallen’s renowned pharma OPEX benchmarking, we have gathered extensive information in workshops and interviews with MedTech companies and experts. We then jointly developed the questionnaire, honing the benchmarking into a precise tool to deliver meaningful insights to MedTech companies.

Further information

If you’d like to know more about the unique MedTech OPEX benchmark, please contact the authors.

The FAQ section below also answers some of the most common questions.

FAQs

Who can participate?

Any MedTech company (medical device and diagnostics manufacturers) and its manufacturing sites.

When can I start?

Any time – just reach out to us.

How long does the benchmarking take?

It can be completed in six to eight weeks. However, this depends heavily on commitment from the site(s) providing data and data availability.

What happens if we don’t provide all the required data – can we still participate?

Yes. The goal is not to provide data for every single point in the questionnaire, but we do require a certain amount to compare your organization to your peers. We can guide you on how to calculate KPIs.

How do you ensure a meaningful comparison?

We have two means of creating a meaningful comparison:

  1. We create peer groups with common contextual factors such as product groups – no opaque adjustments or algorithms. At the same time, we ensure the peer group is large enough.
  2. We realistically compare your company to high performers. High-performer values are actually achievable and prevent single-metric misinterpretation; the best in one KPI may be the worst in 10 others, for instance. The comparison to your peers accounts for trade-offs.

My organization has a special product or portfolio, making benchmarking complex. How does this work?

Your company is unique. But together, we’ll identify a suitable peer group at the beginning of our work together. We also make peer group characteristics transparent in the report, ensuring results and discussions are shown contextually.

Our manufacturing site(s) produces more than one product group. How do you handle this?

We distinguish between product groups, so this isn’t a problem. We ask for separate KPIs per product group, even within the same manufacturing site.

What happens with our data?

Your data is handled confidentially, and you retain full control over your data. An NDA/CDA can be signed. The database is stored on Swiss servers and access is limited exclusively to the St.Gallen team.

Will we see who participated in the past?

No. Data and participation is confidential and anonymous. Data shown in the report is aggregated and anonymized, which makes it impossible to trace back. Your peer group will be described with contextual factors but no names will be stated.

What are the costs and anticipated effort?

We estimate one FTE week of effort per manufacturing site. Costs depend on the number of manufacturing sites and volume of product groups manufactured per site. Please contact us for more information.

Sign up for our newsletter

Further readings
Load More